Abstract:Insulin is a cornerstone in the treatment of diabetes, being life-saving for patients with type 1 diabetes and a therapeutic option for patients with type 2 diabetes. In the latter, insulin treatment is usually implemented either to treat metabolic decompensation at disease onset or in patients with long-standing disease in whom insulin secretory capacity is unresponsive to therapy.1 Insulin, a hormone with a considerable number of pleiotropic actions beyond its ability to regulate glucose levels, is lipogenic, exerts a powerful anabolic activity, and stimulates sodium reabsorption by the distal nephron. As occurs in the majority of patients with type 2 diabetes, when obesity develops beta cells are forced to secrete more insulin to keep blood glucose levels normal. This situation, mostly determined by the expansion of fat tissue, is identified as insulin resistance.2 In this condition, circulating insulin levels are significantly higher and become even higher during exogenous insulin treatment. Despite this, and when necessary, insulin therapy becomes essential to fully accomplish the metabolic effects of the hormone. Thus, paradoxically, human beings have converted a physiologic hormone into a pathologic one with their wrong lifestyle and the subsequent expansion of fat mass.3 This results in weight gain, sodium retention, and noradrenergic activation, which all, along with insulin-induced hypoglycaemia, are important risk factors for heart failure (HF). It is therefore not surprising that insulin treatment may be associated with an increased odd of congestion and hospitalization for HF, especially if the patient’s metabolic control is not at target and repeated hypoglycaemic episodes occur.4 With this background in mind, Cosmi and colleagues assessed in four randomized controlled trials (RCTs) and in a real-world survey whether insulin treatment was associated with an increased risk of hospitalization for HF.5 Given that patients receiving insulin are usually older, co-morbid, and with longer duration of the disease than those who are not on insulin, the authors used propensity

Knowledge Grounded Pre-Trained Model for Dialogue Response Generation.

Knowledge-Grounded Dialogue Generation with Pre-trained Language Models

Improving Dialogue Generation via Proactively Querying Grounded Knowledge

Insulin treatment in patients with diabetes and heart failure: defendant on the stand

Low-Resource Knowledge-Grounded Dialogue Generation

Grounding Dialogue Systems via Knowledge Graph Aware Decoding with Pre-trained Transformers

KRP-DS: A Knowledge Graph-Based Dialogue System with Inference-Aided Prediction

Learning to Select Knowledge for Response Generation in Dialog Systems

DialogVED: A Pre-trained Latent Variable Encoder-Decoder Model for Dialog Response Generation

Knowledge-Grounded Dialogue with Reward-Driven Knowledge Selection

Improving knowledge-based dialogue generation through two-stage knowledge selection and knowledge selection-guided pointer network

Select, Extend, and Generate: Generative Knowledge Selection for Open-Domain Dialogue Response Generation.

KPT: Keyword-guided Pre-training for Grounded Dialog Generation

Emotion-and-knowledge grounded response generation in an open-domain dialogue setting

Building Knowledge-Grounded Dialogue Systems with Graph-Based Semantic Modeling

Learning Multi-turn Response Selection in Grounded Dialogues with Reinforced Knowledge and Context Distillation

Improving Knowledge-Aware Dialogue Response Generation by Using Human-Written Prototype Dialogues.

Knowledge-aware Attentive Wasserstein Adversarial Dialogue Response Generation

Infusing internalized knowledge of language models into hybrid prompts for knowledgeable dialogue generation

Learning to Express in Knowledge-Grounded Conversation